Clinical Trials Directory

Trials / Completed

CompletedNCT06250075

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer

Effects of the Use of Probiotics on the Intestinal Microbiota, Clinical-Nutritional and Immunological Status of Patients Gastrectomized for Gastric Cancer: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Universidade Federal do Amazonas · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this randomized controlled, prospective clinical study, composed of 5 groups, G1, G2, G3, G4 and G5 is \[Evaluate the intestinal microbiota profile, nutritional, immunological status and inflammatory profile, before and after total or partial removal surgery (gastrectomies) for gastric cancer, in a patient using probiotic supplements.\] The main questions it aims to answer are: * probiotics are capable of modulating the immune response and microbiota in cancer patients who will undergo surgery * surgery itself alters the immunological pattern and microbiota of cancer patients Participants will be divided into groups for evaluation and the G1 intervention group will take probiotic capsules. The researchers will compare groups G1, G2 with G3 (negative control group) to see if there are differences between using probiotics or not, in controlling the immune response and if there are significant changes in their intestinal microbiota. Groups G4 and G5 will also be compared, where in these we will only measure the power of the use of probiotics in reducing surgical complications in the postoperative period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFormulation with probioticsLactobacillus acidophilus NCFM®, Lactobacillus paracasei Lpc-37 ™, Bifidobacterium lactis Bi-04™, Bifidobacterium lactis Bi-07™, Bifidobacterium bifidum Bb-02™)
OTHERNon-intervention for Clinical Outcomes -G5only observation of clinical outcomes in the postoperative period

Timeline

Start date
2020-12-12
Primary completion
2022-08-04
Completion
2024-04-26
First posted
2024-02-08
Last updated
2024-05-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06250075. Inclusion in this directory is not an endorsement.